A 61 year old woman was advised to switch from tamoxifen to an aromatase inhibitor (AI) 3 years after starting tamoxifen for hormone receptor positive breast cancer. She asked for a second opinion. This is a common question. Here is the data. What would you do knowing this information?
Here is a PAPER.